IBMS/ECTS 2001 - PROGRAM and ABSTRACTS

ORAL PRESENTATIONS 7b

OSTEOPOROSIS

Chairs: Manuel Sosa Henriquez (Las Palmas de G.C./Spain),
Jacques P. Brown (Ste-Foy, Quebec/Canada)

Saturday, June 9, 2001
17:30 - 19:10 Auditorium

The abstract text of oral presentations (prefix OR) can be found in the Abstracts section. Click on the Abstract number.

17:30 OR63

DISEASES AND DRUGS ASSOCIATED WITH OSTEOPOROSIS PREDICT FRACTURES AT DIFFERENT SITES

T. P. van Staa*, H. G. M. Leufkens, C. Cooper

Department of Pharmacoepidemiology and Pharmacotherapy, University of Utrecht, Sorbonnelaan 16, Utrecht, the Netherlands; Medical Research Council Environmental Epidemiology Unit, Southampton University Hospital, Southampton, United Kingdom; Procter & Gamble Pharmaceuticals, Lovett House, Lovett Road, Staines, United Kingdom

17:42 OR64

EARLY ONSET AND SUSTAINED EFFICACY OF RALOXIFENE ON INCIDENT VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: 4-YEAR RESULTS FROM THE MORE TRIAL

H. Pols, R. Eastell, P. Delmas, J. Adachi, K. Ensrud, K. Harper, S. Sarkar, C. Gennari, J. Y. Reginster, R. Recker, S. Harris, W. Wu, D. Black, H. Genant

Erasmus University, Rotterdam, The Netherlands; University of Sheffield, UK; INSERM, Lyon, France; McMaster University, Hamilton, Canada; VA Medical Center, Minneapolis, USA; Eli Lilly and Company, Indianapolis, USA; University of Siena, Siena, Italy; CHU Centre-Ville, Liège, Belgium; Creighton University, Omaha, USA; UCSF, San Francisco, USA

17:54 OR65

A PROSPECTIVE POPULATION-BASED POST-FRACTURE OSTEOPOROSIS INTERVENTION

M. T. Cuddihy*, S. E. Gabriel, P. C. Amadio, S. Khosla, R. Kurland, W. M. O'Fallon, L. J. Melton Iii

Mayo Clinic and Mayo Foundation, Rochester, MN, USA; Olmsted Medical Center, Rochester, MN, USA

18:06 OR66

EFFECTS OF LY333334 [RECOMBINANT PARATHYROID HORMONE (1-34)] ON CORTICAL BONE STRENGTH INDICES AS ASSESSED BY PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY

J. R. Zanchetta*, C. Bogado, J. L. Ferretti, O. Wang, M. Sato, G. A. Gaich

Instituto de Investigaciones Metabolicas and USAL University School of Medicine, Buenos Aires, AR; Eli Lilly and Company, Indianapolis, IN, USA

18:18 OR67

BMP-6 RESTORES LOST BONE

M. Basic-Koretic*, V. Kusec, J. Buljan-Culej, G. Grahovac, A. Grskovic, M. Habek, M. Ljubic, I. Vukoja, K. Vukovic, S. Vukicevic

Department of Anatomy, School of Medicine, University of Zagreb, Zagreb, Croatia; Central Laboratory, University Hospital Zagreb, Zagreb, Croatia

18:30 OR68

INTRAVENOUS IBANDRONATE IN THE TREATMENT OF CORTICOID-INDUCED OSTEOPOROSIS

J. D. Ringe*, A. Dorst, H. Faber, K. Ibach, K. Mammes

Med. Klinikum 4, University of Cologne, Leverkusen, Germany

18:42 OR69

A POTENT NON-PEPTIDE ANTAGONIST OF ALPHA V. BETA 3 INTEGRIN INHIBITS CALCIUM MOBILIZATION IN THYROPARATHYROIDECTOMIZED RATS AND INHIBITS BONE RESORPTION IN OVARIECTOMIZED CYNOMOLGUS MACAQUES

S. B. Rodan*, M. E. Duggan, L. T. Duong, J. E. Fisher, M. A. Gentile, G. D. Hartman, N. C. Ihle, D. Kimmel, C-T. Leu, R. Nagy, J. G. Seedor, G. Wesolowski, A. E. Zartman, G. A. Rodan

Merck Research Laboratories, West Point, Pennsylvania, USA

18:54 OR70

LOW CONCENTRATIONS OF MEVASTATIN INHIBIT BONE RESORPTION IN VITRO

K. J. Armour*, K. E. Armour, R. J. van't Hof, C. E. Clarkin, M. H. Helfrich, S. H. Ralston, M. J. Rogers

University of Aberdeen, Aberdeen, UK

[Saturday at a Glance] [Contents page]